NYSEARCA:IDNA
iShares Genomics Immunology and ETF News
$23.23
-0.510 (-2.15%)
At Close: May 10, 2024
ARK Genomic Revolution ETF: Value Realization Will Take Time
04:46am, Monday, 03'rd May 2021
ARK Genomic Revolution ETF: Value Realization Will Take Time
Healthcare Dashboard For April And Focus On IDNA
01:23pm, Thursday, 15'th Apr 2021
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month.
Best Biotech ETFs for Q2 2021
02:25pm, Wednesday, 03'rd Feb 2021
The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant
01:02pm, Friday, 29'th Jan 2021
Genomics, immunology, and healthcare ETFs have provided strong returns vs the healthcare sector. RKG has led the way but is not the only option.
Top-Performing Biotech ETFs Amid the COVID-19 Crisis
05:18pm, Tuesday, 29'th Dec 2020
The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.
Megatrends To Invest In Now: 3 Best ETF Picks
03:38pm, Wednesday, 16'th Dec 2020
BlackRock has identified five big trends that are here to stay for the long haul. Investors can get exposure to these drivers via 17 iShares ETFs.
Go Beyond Trends: Healthcare Megatrends with the IDNA ETF
01:20pm, Wednesday, 09'th Dec 2020
ETF investors looking ahead to 2021 tend to seek out current trends, but the megatrends run much deeper. These are the large-scale undercurrents that can disrupt a whole sector.
ETF Strategies to Tap into Medical Breakthroughs, Healthcare Innovations
04:38pm, Friday, 30'th Oct 2020
The election year and the coronavirus has highlighted the importance of an adaptive health industry that meets up with quickly changing times. Investors can also tap into this evolution in healthcare
S&P Forecasts And Strongly Outperforming Funds
08:26pm, Wednesday, 22'nd Jul 2020
Q4 S&P earnings forecasts not realistic if COVID spikes, or elections litigated, or protest/riots metastisize.
Biotech ETFs to watch as companies push for coronavirus treatments
07:42pm, Monday, 18'th May 2020
Yahoo Finance's Seana Smith and ETF Trends CIO and Director Dave Nadig discuss the outlook on biotech ETFs as optimism grows over results for coronavirus treatments.
Biotech ETFs trade higher on upbeat coronavirus results
02:51pm, Monday, 18'th May 2020
Biotechnology-themed exchange-traded funds surged higher late Monday morning as investors rewarded pharmaceutical companies that looked likely to profit from treatments for COVID-19. The SPDR S&P; Bio
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners
06:30pm, Friday, 24'th Apr 2020
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners
06:30pm, Friday, 24'th Apr 2020
Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.
USO, OIL, TQQQ and SQQQ among weekly ETF movers
03:51am, Saturday, 18'th Apr 2020
Gainers: DB Crude Oil -2X ETN Powershares (NYSEARCA:DTO) +81.4%.BMO Rex Microsectors Fang Index 3X Leveraged Ex (NYSEARCA:FNGU) +35.0%.Direxion S&P Biotech Bull 3X (NYSEARCA:LABU) +30.2%.Ultrashor
Coronavirus Scare Supports These Biotech ETFs & Stocks
12:00pm, Tuesday, 24'th Mar 2020
Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.
